Vanda Pharmaceuticals rejects Cycle Pharma’s second takeover offer
(Reuters) -Vanda Pharmaceuticals on Monday rejected UK-based Cycle Pharmaceuticals’ second takeover proposal, which values the drugmaker at $8 per share despite a
(Reuters) -Vanda Pharmaceuticals on Monday rejected UK-based Cycle Pharmaceuticals’ second takeover proposal, which values the drugmaker at $8 per share despite a
By Marcela Ayres and Bernardo Caram BRASILIA (Reuters) – The Brazilian government is preparing to roll out measures to curb mandatory spending after
ISTANBUL (Reuters) – Turkey’s economy will grow 3% this year and next, lower than the government’s recently updated forecasts, a Reuters poll
By Lisa Pauline Mattackal and Purvi Agarwal (Reuters) -Wall Street rose on Monday, with the S&P 500 and the Dow touching fresh intraday
SAO PAULO (Reuters) – Half a million consumers in Latin America’s largest city are still without electricity three days after a violent
Investing.com – U.K. stocks were higher after the close on Monday, as gains in the Automobiles & Parts, Electrical and Gas, Water
Investing.com – Spain stocks were higher after the close on Monday, as gains in the Chemical, Petroleum & Plastic, Financial Services &
Investing.com – Portugal stocks were lower after the close on Monday, as losses in the Utilities, Consumer Services and Basic Materials sectors
BRASILIA (Reuters) – Brazil’s Finance Minister Fernando Haddad said on Monday that the government might need to revise its economic growth forecast
By Michael S. Derby (Reuters) – U.S. Federal Reserve Bank of Minneapolis President Neel Kashkari said on Monday more rate cuts likely lie